Open AccessODAC Recommends Deferral of Decision on Satraplatin Until All Survival Data Are Available
Author(s) -
Margot J. Fromer
Publication year - 2007
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000288875.02501.8c
Subject(s) - medicine , docetaxel , mitoxantrone , taxane , oncology , prostate cancer , cancer , cabazitaxel , clinical trial , clinical endpoint , chemotherapy , breast cancer , androgen deprivation therapy